SELLAS Life Sciences
SLS
SLS
93 hedge funds and large institutions have $53M invested in SELLAS Life Sciences in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.43% more ownership
Funds ownership: 26.83% → 31.26% (+4.4%)
10% less capital invested
Capital invested by funds: $58.6M → $53M (-$5.62M)
Holders
93
Holding in Top 10
–
Calls
$27.8M
Puts
$333K
Top Buyers
| 1 | +$9.27M | |
| 2 | +$1.77M | |
| 3 | +$533K | |
| 4 |
Renaissance Technologies
New York
|
+$470K |
| 5 |
State Street
Boston,
Massachusetts
|
+$400K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$1.01M | |
| 3 | -$718K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$576K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$362K |
